pioglitazone and glimepiride (Prasco Laboratories)
Welcome to the PulseAid listing for the pioglitazone and glimepiride drug offered from Prasco Laboratories. This Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Prasco Laboratories |
| NON-PROPRIETARY NAME: | pioglitazone and glimepiride |
| SUBSTANCE NAME: | PIOGLITAZONE HYDROCHLORIDE; GLIMEPIRIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-08-04 |
| END MARKETING DATE: | 0000-00-00 |
pioglitazone and glimepiride HUMAN PRESCRIPTION DRUG Details:
| Item Description | pioglitazone and glimepiride from Prasco Laboratories |
| LABELER NAME: | Prasco Laboratories |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30; 2(mg/1; mg/1) |
| START MARKETING DATE: | 2015-08-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66993-821_ebc5da9b-2185-4f20-b5cc-7530ebe3bc63 |
| PRODUCT NDC: | 66993-821 |
| APPLICATION NUMBER: | NDA021925 |
Other PIOGLITAZONE HYDROCHLORIDE; GLIMEPIRIDE Pharmaceutical Manufacturers / Labelers:
